🇬🇧 The iBox algorithm in Kidney transplantation
Nov 10, 2020 | 3:30 PM CET - 3:45 PM CET
Nov 10, 2020 | 3:30 PM CET - 3:45 PM CET
Description
Collaboration between start-ups and pharma companies has increased over the last years aiming to improve patients follow-up. Cibiltech, a Paris-based start-up developing software solutions based on the iBox algorithm, a prognostic AI tool that predicts graft survival in kidney transplant patients, is now collaborating with Novartis to support a new medicine registration. Novartis has incorporated the iBox algorithm into their registration trial for an innovative new organ transplant treatment, dramatically decreasing the time to access to new medicine for patients.
